Drugs / Glioma-related multi-target mRNA vaccines
Glioma-related multi-target mRNA vaccines
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07306299 | Dec 2025 → Jan 2028 expected | high grade astrocytic tumor | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glioma-related multi-target mRNA vaccines | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07306299 ↗ |
| Modality | Messenger RNA (mRNA) | “Multi-targeted mRNA vaccines encoding the following GBM-associated mutations” NCT07306299 ↗ |